THE VALUE of the cortisone and cortisone-like ( hydrocortisone) hormones in relieving symptoms and temporarily halting the altered processes of allergy has been adequately established and is well known.*
However, the problems incidental to their utilization on a systemic basis are considerable, and it is generally accepted that their systemic use should be limited to the temporary alleviation of severe reactions that endanger the vital functions of the patient.2 It is obvious that few of the nasal afflictions fit into this category. Yet the problems incidental to nasal allergy are manifold and are difficult to control.† Nasal obstruction, nasal polyposis, postnasal drainage, chronic pansinusitis, catarrhal otitis media, and chronic bronchitis are closely related to the problem of upper respiratory allergy. Even though great advances in the treatment of these conditions have recently been made, especially by Hansel and his group, the management is not entirely adequate. It is apparent that